Today: 11 June 2026
Citigroup stock slides after-hours as Trump credit-card rate cap stays in focus
21 January 2026
1 min read

Citigroup stock slides after-hours as Trump credit-card rate cap stays in focus

New York, Jan 20, 2026, 19:50 EST — After-hours

  • Citigroup shares slipped roughly 4.4% post-close, dragging along with a wider slump in U.S. bank stocks.
  • CEO Jane Fraser said she doesn’t anticipate Congress will approve any caps on credit-card interest rates.
  • Traders are waiting on clearer signals from Washington to see if the proposal will become policy.

Citigroup shares slipped 4.4% to $112.80 in after-hours trading Tuesday, following a steep fall during the regular session. Investors are reacting to new concerns over U.S. credit-card pricing policies.

The stock move is significant as the discussion pivots from campaign rhetoric to immediate action, pushing bank executives to assess how a hard cap might impact consumer lending. Citi CEO Jane Fraser expressed skepticism that Congress will greenlight limits on credit-card interest rates, cautioning that such measures could restrict credit availability.

Credit cards are unsecured loans, meaning they aren’t backed by collateral. That risk forces lenders to set higher prices. A forced cap would shrink that margin, which is why bank shares have taken a hit even though no clear rules are set yet.

The Trump administration urged companies to meet the deadline by Tuesday, but questions remain about whether the cap can be enforced without new legislation. The S&P 500 banks index dropped 1.2%, with Citigroup and other major banks also sliding. Brian Jacobsen, chief economic strategist at Annex Wealth Management, described the situation as “an overhang” for now. Reuters

Industry groups have attempted to quantify the impact. The American Bankers Association, citing new data from issuers that cover about 75% of the market, estimates that between 137 million and 159 million cardholders might lose credit access. ABA President and CEO Rob Nichols cautioned that these caps “lead to fewer options.” aba.com

The Consumer Bankers Association highlighted a Morning Consult survey revealing that 60% of adults anticipate banks would introduce new fees and tighten approvals if a 10% cap were enforced. Lindsey Johnson, CBA’s President and CEO, warned the move would “hurt consumers” by shrinking credit availability and jeopardizing rewards programs. consumerbankers.com

Treasury Secretary Scott Bessent, speaking from Davos, called it “not unreasonable” to discuss credit-card company practices, indicating the issue remains firmly on the policy radar. Reuters

Outside Washington, Citi is stepping up its investment banking staff by bringing in senior hires as it rebuilds its coverage teams. That includes a new head of media banking, according to the Wall Street Journal.

Citi bulls face the possibility that Tuesday’s slide isn’t over. Should the cap turn into a strict rule—or if lawmakers push through legislation—banks might clamp down on credit, slash rewards, and crank up fees. That would ripple through consumer spending and dent bank profits.

Traders on Wednesday are eager for a clear sign on enforcement—will the White House press Congress, opt for an executive path, or settle on a voluntary “low-rate” card proposal that softens the blow to banks’ earnings?

Stock Market Today

  • US Stocks Rise on AI Gains as Oil Prices Steady Amid Iran War Concerns
    June 11, 2026, 10:56 AM EDT. US stock indices climbed on Thursday, led by artificial intelligence (AI) stocks driving gains in chipmakers like Marvell Technology (+4.3%) and Intel (+10.4%). The S&P 500 rose 0.6%, with the Nasdaq up 0.8% and the Dow gaining 0.7%. Despite escalating tensions in the Iran war, oil prices held steady, with Brent crude easing 1.1% to $92.08 per barrel and U.S. crude down 0.6% to $89.52. The market showed resilience despite concerns over inflation pressures fueled by higher wholesale prices and renewed geopolitical risks. Oracle fell 10.3% after announcing substantial planned borrowing and equity sales to fund AI investments, reflecting investor caution on aggressive spending amidst uncertainty.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Previous Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

BAE Systems share price: fresh buyback filing hits tape before London open
Next Story

BAE Systems share price: fresh buyback filing hits tape before London open

Go toTop